Cargando…

MicroRNA 34a–AXL Axis Regulates Vasculogenic Mimicry Formation in Breast Cancer Cells

Targeting the tumor vasculature is an attractive strategy for cancer treatment. However, the tumor vasculature is heterogeneous, and the mechanisms involved in the neovascularization of tumors are highly complex. Vasculogenic mimicry (VM) refers to the formation of vessel-like structures by tumor ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Dansaem, Cho, Jin Gu, Yun, Eunsik, Lee, Aram, Ryu, Hong-Yeoul, Lee, Young Joo, Yoon, Sukjoon, Chang, Woochul, Lee, Myeong-Sok, Kwon, Byung Su, Kim, Jongmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823537/ https://www.ncbi.nlm.nih.gov/pubmed/33374832 http://dx.doi.org/10.3390/genes12010009

Ejemplares similares

Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer
por: Lim, Dansaem, et al.
Publicado: (2020)

Ginsenoside Rg3 protects against iE-DAP–induced endothelial-to-mesenchymal transition by regulating the miR-139-5p–NF-κB axis
por: Lee, Aram, et al.
Publicado: (2020)

Vasculogenic mimicry
por: Pandiar, Deepak, et al.
Publicado: (2023)

Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction
por: Cho, Jin Gu, et al.
Publicado: (2018)

Advanced research on vasculogenic mimicry in cancer
por: Qiao, Lili, et al.
Publicado: (2015)

Mechanisms of Vasculogenic Mimicry in Ovarian Cancer
por: Ayala-Domínguez, Lízbeth, et al.
Publicado: (2019)

An Overview of Vasculogenic Mimicry in Breast Cancer
por: Andonegui-Elguera, Marco A., et al.
Publicado: (2020)

Vasculogenic mimicry in carcinogenesis and clinical applications
por: Luo, Qingxi, et al.
Publicado: (2020)

Endothelial to Mesenchymal Transition in Pulmonary Vascular Diseases
por: Yun, Eunsik, et al.
Publicado: (2020)

MicroRNA-dependent inhibition of WEE1 controls cancer stem-like characteristics and malignant behavior in ovarian cancer
por: Cho, Jin Gu, et al.
Publicado: (2022)

Clinical significance of vasculogenic mimicry in human gliomas
por: Liu, Xiao-mei, et al.
Publicado: (2011)

Slug promoted vasculogenic mimicry in hepatocellular carcinoma
por: Sun, Dan, et al.
Publicado: (2013)

Vasculogenic mimicry in small cell lung cancer
por: Williamson, Stuart C., et al.
Publicado: (2016)

Structural and functional identification of vasculogenic mimicry in vitro
por: Racordon, Dusan, et al.
Publicado: (2017)

Editorial: Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
por: López-Camarillo, César, et al.
Publicado: (2020)

Platelets disrupt vasculogenic mimicry by cancer cells
por: Martini, Carmela, et al.
Publicado: (2020)

Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments
por: Wei, Xiaoxu, et al.
Publicado: (2021)

Therapeutic potential of vasculogenic mimicry in urological tumors
por: Lin, Xinyu, et al.
Publicado: (2023)

Advance in vasculogenic mimicry in ovarian cancer (Review)
por: Tian, Xinyuan, et al.
Publicado: (2023)

Ginsenoside Rg3 attenuates pulmonary fibrosis by inhibiting endothelial to mesenchymal transition
por: Yun, Eunsik, et al.
Publicado: (2023)

Endothelial miR-26a regulates VEGF-Nogo-B receptor-mediated angiogenesis
por: Jo, Ha-neul, et al.
Publicado: (2017)

ZRANB2/SNHG20/FOXK1 Axis regulates Vasculogenic mimicry formation in glioma
por: Li, Xiaozhi, et al.
Publicado: (2019)

Vasculogenic mimicry: a novel target for glioma therapy
por: Chen, Yin-Sheng, et al.
Publicado: (2014)

The relationship between vasculogenic mimicry and epithelial‐mesenchymal transitions
por: Liu, Qiqi, et al.
Publicado: (2016)

Vasculogenic mimicry formation in EBV-associated epithelial malignancies
por: Xiang, Tong, et al.
Publicado: (2018)

Vasculogenic Mimicry: Become an Endothelial Cell “But Not So Much”
por: Fernández-Cortés, Mónica, et al.
Publicado: (2019)

Fact or Fiction, It Is Time for a Verdict on Vasculogenic Mimicry?
por: Valdivia, Andrés, et al.
Publicado: (2019)

Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors
por: Hernández de la Cruz, Olga N., et al.
Publicado: (2020)

Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry
por: Zhang, Xue, et al.
Publicado: (2019)

Vasculogenic Mimicry Formation Predicts Tumor Progression in Oligodendroglioma
por: Xie, Jing, et al.
Publicado: (2021)

Tyrosinase suppresses vasculogenic mimicry in human melanoma cells
por: Kamo, Hiroki, et al.
Publicado: (2022)

Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers
por: Morales-Guadarrama, Gabriela, et al.
Publicado: (2021)

Vasculogenic mimicry structures in melanoma support the recruitment of monocytes
por: Tan, Lih Y., et al.
Publicado: (2022)

Physicochemical aspects of the tumour microenvironment as drivers of vasculogenic mimicry
por: Andreucci, Elena, et al.
Publicado: (2022)

FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer
por: Recouvreux, Maria Sol, et al.
Publicado: (2022)

Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension
por: Kim, Jun-Dae, et al.
Publicado: (2015)

Thalidomide influences growth and vasculogenic mimicry channel formation in melanoma
por: Zhang, Shiwu, et al.
Publicado: (2008)

Galunisertib inhibits glioma vasculogenic mimicry formation induced by astrocytes
por: Zhang, Chao, et al.
Publicado: (2016)

Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib
por: Serova, Maria, et al.
Publicado: (2016)

The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma
por: Pulford, Emily, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a7pm503bd75ogptlmuc7fprdft